Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
Some normal-hearing carriers of heterozygous missense variants of KCNE1 and KCNQ1 have prolonged QT intervals, a dominantly inherited phenotype designated Romano-Ward syndrome (RWS), which is also associated with arrhythmias and elevated risk of sudden death.
|
30461122 |
2019 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
Transient myocardial ischemia may have exaggerated the instability from the arrhythmic substrate, even though KCNE1-D85N abnormalities alone are not thought to cause fatal arrhythmias.
|
31308327 |
2019 |
Cardiac Arrhythmia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
In the heart, KCNQ1 associates with KCNE1 subunits to form I<sub>Ks</sub> channels that regulate heart rhythm.
|
31329101 |
2019 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
Patients with KCNE1(G38S) had a rate-dependent repolarization abnormality similar to patients with LQT2 and, therefore, may have a potential risk to develop lethal arrhythmias.
|
27255646 |
2017 |
Cardiac Arrhythmia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
We have created a novel transgenic LQT5 rabbit model with increased susceptibility to drug-induced arrhythmias that may represent a useful model for testing proarrhythmic potential and for investigations of the mechanisms underlying arrhythmias and sudden cardiac death due to repolarization disturbances.
|
27076034 |
2016 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in either KCNQ1 or KCNE1 genes lead to life-threatening cardiac arrhythmias causing long QT syndrome, short QT syndrome, sinus bradycardia and atrial fibrillation.
|
24721657 |
2014 |
Cardiac Arrhythmia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
KCNE1, a membrane protein that spans the membrane once is responsible for modulating potassium channel functions and plays an important role in the etiology of arrhythmia.
|
25366730 |
2014 |
Cardiac Arrhythmia
|
0.300 |
Biomarker
|
phenotype |
RGD |
Dynamic changes in HCN2, HCN4, KCNE1, and KCNE2 expression in ventricular cells from acute myocardial infarction rat hearts.
|
20381460 |
2010 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
Rate-dependent facilitation of K(+) conductance, a key property of I(Ks) that enables action potential shortening at higher heart rates, was defective for both KCNE1 C-terminal mutations, and may contribute to the clinical phenotype of arrhythmias triggered by heart rate elevations during exercise in LQTS mutations.
|
19340287 |
2009 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
We demonstrate that each additional copy of the KCNE1 D85N minor allele is associated with a considerable 10.5 ms prolongation of the age-, gender- and heart rate-adjusted QT interval and could thus modulate repolarization-related arrhythmia susceptibility at the population level.
|
19019189 |
2009 |
Cardiac Arrhythmia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
KCNE1 encodes the beta-subunit of cardiac voltage-gated K(+) channels and causes LQTS, which is characterized by the prolongation of the QT interval and torsades de pointes, a lethal arrhythmia.
|
19695459 |
2009 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
To detect single nucleotide polymorphisms (SNP) in SCN5A, KCNQ1 and KCNE1 of post-MI patients, and to assess whether they are related to electrophysiological markers of cardiac arrhythmia (QT interval) and the clinical course.
|
18803136 |
2008 |
Cardiac Arrhythmia
|
0.300 |
GeneticVariation
|
phenotype |
BEFREE |
Because KVLQT1 mutations cause arrhythmia susceptibility in the long QT syndrome (LQT), we hypothesized that mutations in KCNE1 also cause this disorder.
|
9354802 |
1997 |